Static magnetic field attenuates mortality rate of mice by increasing the production of IL-1 receptor antagonist

References

• Aldinucci C, Garcia J B, Oalmi M, Sgaragli G, Benocci A, Meini A, Pessina F, Rossi C, Bonechi C, Pessina G P. The effect of strong static magnetic field on lymphocytes. Bioelectromagnetics 2003; 24: 109–117
   PubMed Web of Science ®Google Scholar
• Asakura H, Takahashi Y, Kubo A, Ontachi T, Hayashi T, Omote M, Arahata M, Kadohira Y, Maekawa M, Yamazaki M, Morishita E, Takami A, Yoshida T, Miyamoto K, Nakao S. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats. Critical Care Medicine 2006; 34: 2421–2425
   PubMed Web of Science ®Google Scholar
• Ashdown H, Poole S, Boksa P, Luheshi G N. Interleukin-1 receptor antagonist as a modulator of gender differences in the febrile response to lipopolysaccharide in rats. The American Journal of Physiology – Regulatory, Integrative and Comparative Physiology 2007; 292: R1667–R1674
   PubMed Web of Science ®Google Scholar
• Bakhshi S, Arya L S. Etiopathophysiology of disseminated intravascular coagulation. Journal of the Association of Physicians of India 2003; 51: 796–800
   PubMedGoogle Scholar
• Cummins D, Segal H, Hunt B J, Awad R, Maddox A. Chronic disseminated intravascular coagulation after surgery for abdominal aortic aneurysm: Clinical and haemostatic response to dalteparin. British Journal of Haematology 2001; 113: 658–660
   PubMed Web of Science ®Google Scholar
• Dempfle C E. Coagulopathy of sepsis. Thrombosis and Haemostasis 2004; 91: 213–224
   PubMed Web of Science ®Google Scholar
• Dinarello C A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International Reviews of Immunology 1998; 16: 457–499
   PubMedGoogle Scholar
• Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz1 B. Evaluation of serum levels of interleukin (IL)- 6, IL-10, and tumor necrosis factor-A in patients with Crimean-Congo hemorrhagic fever. The Journal of Infectious Diseases 2006; 193: 941–944
   PubMed Web of Science ®Google Scholar
• Feinstein D I. Diagnosis and management of disseminated intravascular coagulation: The role of heparin therapy. Blood 1982; 60: 284–287
   PubMed Web of Science ®Google Scholar
• Fourrier F, Chopin C, Goudemand J, Hendryscx S, Caron C, Rime A, Marey A, Lestavel P. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816–823
   PubMed Web of Science ®Google Scholar
• Goldbach-Mansky R, Dailey N J, Canna S W, Gelabert A, Jones J, Rubin B I, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. The New England Journal of Medicine 2006; 355: 581–592
   PubMed Web of Science ®Google Scholar
• Gullestad L, Aass H, Fjeld J G, Wikeby L, Andreassen A K, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland S S, Aukrust P. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 2001; 103: 220–225
   PubMed Web of Science ®Google Scholar
• Hardaway R M. A review of septic shock. The American Surgeon 2000; 66: 22–29
   PubMed Web of Science ®Google Scholar
• Kakafika A, Papadopoulos V, Mimidis K, Mikhailidis D P. Coagulation, platelets, and acute pancreatitis. Pancreas 2007; 34: 15–20
   PubMed Web of Science ®Google Scholar
• Kishimoto C, Shioji K, Kinoshita M, Iwase T, Tamaki S, Fujii M, Murashige A, Maruhashi H, Takeda S, Nonogi H, Hashimoto T. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. International Journal of Cardiology 2003; 91: 173–178
   PubMed Web of Science ®Google Scholar
• Lin C T, Lee S Y, Chen C Y, Chen C A, Lin C P, Huang H M. Long-term continuous exposure to static magnetic field reduces lipopolysaccharide-induced cytotoxicity of fibroblasts. International Journal of Radiation Biology 2008; 84: 219–226
   PubMed Web of Science ®Google Scholar
• Lynn W A. Anti-endotoxin therapeutic options for the treatment of sepsis. Journal of Antimicrobial Chemotherapy 1998; 41: A71–A80
   PubMed Web of Science ®Google Scholar
• Nahra R, Dellinger R P. Targeting the lipopolysaccharides: Still a matter of debate. Current Opinion in Anaesthesiology 2008; 21: 98–104
   PubMed Web of Science ®Google Scholar
• Norman K E, Cotter M J, Stewart J B, Abbitt K B, Ali M, Wagner B E, Wallace W A, Forlow S B, Hellewell P G. Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation. Blood 2003; 101: 921–928
   PubMed Web of Science ®Google Scholar
• Remick D G. Pathophysiology of sepsis. The American Journal of Pathology 2007; 170: 1435–1444
   PubMed Web of Science ®Google Scholar
• Rodel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. International Journal of Radiation Biology 2007; 6: 357–366
   Google Scholar
• Rothenburger M, Soeparwata R, Deng M C, Berendes E, Schmid C, Tjan T DT, Wilhelm M J, Erren M, Böcker D, Scheld H H. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. Journal of the American College of Cardiology 2001; 38: 124–130
   PubMed Web of Science ®Google Scholar
• Salerno S, Lo Casto A, Caccamo N, D'Anna C, De Maria M, Lagalla R, Scola L, Cardinale A E. Static magnetic fields generated by a 0.5 T MRI unit affects in vitro expression of activation markers and interleukin release in human peripheral blood mononuclear cells (PBMC). International Journal of Radiation Biology 1999; 75: 457–463
   PubMed Web of Science ®Google Scholar
• Sato H, Konishi Y, Tanaka H, Takahashi O, Tanaka T. Annexin V inhibits lipopolysaccharide-induced procoagulant activity on human monocytes. Thrombosis Research 2004; 114: 45–49
   PubMed Web of Science ®Google Scholar
• Saunders R. Static magnetic fields: Animal studies. Progress in Biophysics and Molecular Biology 2005; 87: 225–239
   PubMed Web of Science ®Google Scholar
• Short M A. Linking the sepsis triad of inflammation, coagulation, and suppressed fibrinolysis toinfants. Advances in Neonatal Care 2004; 4: 258–273
   PubMedGoogle Scholar
• Slofstra S H, Cate H T, Spek C A. Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Schwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction. Thrombosis Journal 2006; 4: 13–19
   PubMedGoogle Scholar
• Tilg H, Dinarello C A, Mier J W. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunology Today 1997; 18: 428–432
   PubMedGoogle Scholar
• Toh C H, Dennis M. Disseminated intravascularcoagulation: Old disease, new hope. British Medical Journal 2003; 327: 974–977
   PubMedGoogle Scholar
• Weinberger A, Nyska A, Giler S. Treatment of experimental inflammatory synovitis with continuous magnetic field. Israel Journal of Medical Sciences 1996; 32: 1197–1201
   PubMedGoogle Scholar
• Weiss D J, Rashid J. The sepsis-coagulant axis: A review. Journal of Veterinary Internal Medicine 1998; 12: 317–324
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Environmental health criteria 232 – Static fields. WHO Press, World Health Organisation, Geneva 2006
   Google Scholar